Medulloblastoma exome sequence analysis
Demographics (2)
- Age - Participant's age (phv00171447.v2.p2)
- Gender - Participant's gender as Male or Female (phv00171448.v2.p2)
Race and Ethnicity (1)
- Race - Participant's race using US census definitions (phv00171449.v2.p2)
Other (13)
- ANALYTE_TYPE - Molecular analyte (phv00171455.v2.p2)
- Cho et al. - Six molecular subgroups of medulloblastoma (termed c1 to c6), each with a unique combination of numerical and structural chromosomal aberrations that globally influence mRNA and miRNA expression. For details see: Cho et al., 2011, <a href="http://www.ncbi.nlm.nih.gov/pubmed/21098324">PMID:21098324</a> (phv00196127.v1.p2)
- CONSENT - Consent group as determined by DAC (phv00171442.v2.p2)
- Histological Subtype - Subtype of medulloblastoma as determined by pathology review (phv00196129.v1.p2)
- Northcott et al. - Four distinct, nonoverlapping molecular variants (WNT, SHH, group C, and group D) with significant subgroup-specific demographics, histology, metastatic status, and DNA copy number aberrations. For details see: Northcott et al., 2011 <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20823417">PMID:20823417</a> (phv00196128.v1.p2)
- SAMPID - De-identified Sample ID (phv00171450.v2.p2)
- SAMPID - Sample ID (phv00171444.v2.p2)
- Sample Type - Indicates the Tumor / Normal status of a sample (phv00171451.v2.p2)
- SAMPLE_USE - Sample Use (phv00171445.v2.p2)
- SUBJID - Unique Participant Identifier (phv00171446.v2.p2)
- SUBJID - Subject ID (phv00171443.v2.p2)
- SUBJID - Subject ID (phv00171441.v2.p2)
- Tissue Site - General body site where sample was collected (phv00171452.v2.p2)